Complement-Based Drug Development Summit leaderboard
  • Wednesday, September 2, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 461

Author

Pharma Journalist 9038 posts 0 comments

OliX Announces Expansion of Collaboration with Laboratoires Théa to Develop siRNA Therapeutics for…

Oct 7, 2020
OliX Pharmaceuticals announced a collaboration with Théa Open Innovation, a sister company of Laboratoires Théa S.A.S ("Théa"), the leading independent pharmaceutical company in Europe …
Read More...

Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics

Oct 7, 2020
Citius Pharmaceuticals, Inc. a specialty pharmaceutical company developing and commercializing critical care drug products, announced that it has signed an exclusive agreement with…
Read More...

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating…

Oct 7, 2020
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care Early) study…
Read More...

FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine

Oct 7, 2020
Oragenics, Inc. announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug Administration (“FDA”) that it is in broad agreement with the Company’s…
Read More...

BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine…

Oct 7, 2020
Pfizer Inc. and BioNTech SE announced the initiation of a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the lead candidate from the companies’ vaccine…
Read More...

Registration is now open for RNA Therapeutics 2021

Oct 7, 2020
SMi Group are delighted to announce their 12th annual conference RNA Therapeutics, taking place on 10th - 11th February 2021 at the Copthorne Tara Hotel, London, UK. The 2021…
Read More...

Exclusive interview with Maria Jose Lopez Barragan, formerly FDA released ahead of Pharmaceutical…

Oct 7, 2020
SMi Reports: An exclusive interview with María José López Barragán, Founder, Barragan BioConsulting, formerly CMC Product Quality Reviewer, FDA, who will be speaking at the 3rd Annual…
Read More...

Aro Collaboration with Ionis Advances with Option Exercise

Oct 6, 2020
Aro Biotherapeutics, a biotechnology company focused on developing a new generation of medicines based on its proprietary CENTYRIN technology, announced that Ionis Pharmaceuticals,…
Read More...

Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for…

Oct 6, 2020
Scribe Therapeutics Inc., the company focused on engineering the most advanced platform for CRISPR-based genetic medicine, announced a research collaboration with Biogen Inc. to develop…
Read More...

ImmunoGen Announces FDA Breakthrough Therapy Designation for IMGN632 in Relapsed or Refractory…

Oct 6, 2020
ImmunoGen, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for IMGN632 for the treatment of patients with relapsed or…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
  • Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
  • FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
  • Teva Discusses Lower Medicaid Drug Prices With Trump Administration
  • Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.